Bank of America Begins Coverage on Teladoc Health (NYSE:TDOC)

Share on StockTwits

Bank of America initiated coverage on shares of Teladoc Health (NYSE:TDOC) in a research report released on Thursday morning, Benzinga reports. The brokerage issued a buy rating and a $65.00 price objective on the health services provider’s stock.

Several other equities analysts have also recently issued reports on the stock. Zacks Investment Research raised shares of Teladoc Health from a sell rating to a hold rating in a research note on Friday, May 3rd. Guggenheim initiated coverage on shares of Teladoc Health in a research note on Wednesday, April 17th. They issued a buy rating on the stock. Stephens initiated coverage on shares of Teladoc Health in a research note on Tuesday, April 16th. They issued an overweight rating and a $75.00 price objective on the stock. TheStreet raised shares of Teladoc Health from a d+ rating to a c rating in a research note on Wednesday, February 20th. Finally, SunTrust Banks lifted their price objective on shares of Teladoc Health to $75.00 and gave the stock a positive rating in a research note on Monday, March 4th. Three investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Teladoc Health has a consensus rating of Buy and an average target price of $82.68.

Shares of TDOC stock traded up $0.14 during trading hours on Thursday, reaching $59.40. The stock had a trading volume of 97,267 shares, compared to its average volume of 995,734. The company has a quick ratio of 7.54, a current ratio of 7.54 and a debt-to-equity ratio of 0.42. Teladoc Health has a twelve month low of $42.08 and a twelve month high of $89.05. The stock has a market cap of $4.24 billion, a PE ratio of -41.25 and a beta of 1.26.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, April 30th. The health services provider reported ($0.43) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.44) by $0.01. The firm had revenue of $128.57 million for the quarter, compared to analysts’ expectations of $127.99 million. Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. Teladoc Health’s quarterly revenue was up 43.4% on a year-over-year basis. During the same quarter last year, the company earned ($0.39) EPS. Equities analysts forecast that Teladoc Health will post -1.53 EPS for the current fiscal year.

In related news, CEO Jason N. Gorevic sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 16th. The shares were sold at an average price of $53.04, for a total transaction of $1,591,200.00. Following the completion of the sale, the chief executive officer now directly owns 673,924 shares in the company, valued at $35,744,928.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Andrew Turitz sold 31,960 shares of the firm’s stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $55.82, for a total transaction of $1,784,007.20. Following the sale, the senior vice president now owns 13,455 shares of the company’s stock, valued at $751,058.10. The disclosure for this sale can be found here. Over the last quarter, insiders sold 156,351 shares of company stock valued at $9,088,666. Corporate insiders own 3.95% of the company’s stock.

Several hedge funds have recently bought and sold shares of the stock. Flagship Harbor Advisors LLC raised its position in Teladoc Health by 87.8% during the first quarter. Flagship Harbor Advisors LLC now owns 616 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 288 shares in the last quarter. Pier 88 Investment Partners LLC raised its position in shares of Teladoc Health by 10.2% in the fourth quarter. Pier 88 Investment Partners LLC now owns 3,345 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 310 shares during the period. Nikulski Financial Inc. raised its position in shares of Teladoc Health by 2.7% in the first quarter. Nikulski Financial Inc. now owns 12,295 shares of the health services provider’s stock valued at $684,000 after purchasing an additional 325 shares during the period. Trustcore Financial Services LLC raised its position in shares of Teladoc Health by 100.0% in the first quarter. Trustcore Financial Services LLC now owns 800 shares of the health services provider’s stock valued at $44,000 after purchasing an additional 400 shares during the period. Finally, Synovus Financial Corp raised its position in shares of Teladoc Health by 126.2% in the first quarter. Synovus Financial Corp now owns 778 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 434 shares during the period.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: Current Ratio

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bank of America Begins Coverage on Teladoc Health
Bank of America Begins Coverage on Teladoc Health
Dermira  Stock Rating Upgraded by BidaskClub
Dermira Stock Rating Upgraded by BidaskClub
BiblePay  Hits Market Cap of $814,567.00
BiblePay Hits Market Cap of $814,567.00
CDK Global  Stock Rating Upgraded by BidaskClub
CDK Global Stock Rating Upgraded by BidaskClub
BidaskClub Downgrades Cisco Systems  to Hold
BidaskClub Downgrades Cisco Systems to Hold
Northern Trust Corp Has $474.14 Million Holdings in iShares Core S&P Mid-Cap ETF
Northern Trust Corp Has $474.14 Million Holdings in iShares Core S&P Mid-Cap ETF


© 2006-2019 Ticker Report